Comparing TRIple Rectal Ultrasound Imaging Technology in Ulcerative Colitis
TRINITY
Comparing Three Modalities (Trans Abdominal, Trans-perineal and Endoscopic Ultrasound) of Ultrasonography for Rectal Imaging in Ulcerative Colitis: The TRINITY Study
1 other identifier
interventional
142
1 country
1
Brief Summary
This study aims to evaluate the correlation of rectal wall thickness and vascularity measurements using trans-abdominal ultrasound (TAS), trans-perineal ultrasound (TPUS), and endoscopic ultrasound (EUS) in adult patients with ulcerative colitis (UC). The primary objective is to correlate rectal total wall thickness measured by TPUS with EUS, while secondary objectives include correlating rectal wall thickness and vascularity as measured by TAS, TPUS, and EUS, with endoscopic and histologic activity. Additionally, the study will assess changes in patient management following EUS/sigmoidoscopy compared to TAS/TPUS alone. Consecutive UC patients attending an IBD clinic will undergo clinical assessment using the Simple Clinical Colitis Activity Index (SCCAI) followed by TAS and TPUS as point-of-care tests. If clinically indicated, patients will also undergo sigmoidoscopy and EUS during the same visit, with measurements compared and correlated to histologic inflammation and fecal calprotectin (FCP) levels when available. This cross-sectional study will include a follow-up period until biopsy results are obtained, with a recruitment duration of 6-12 months and a target sample size of 170 patients (60 patients with mid-end ultrasound machine, rest with high-end ultrasound machine for transabdominal and transperineal ultrasound).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 27, 2024
CompletedFirst Submitted
Initial submission to the registry
August 18, 2024
CompletedFirst Posted
Study publicly available on registry
December 5, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2025
CompletedJuly 17, 2025
December 1, 2024
10 months
August 18, 2024
July 14, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Compare diagnostic accuracy of endoscopic ultrasound in predicting endoscopic remission
Wall thickness (in mm) measured by endoscopic ultrasound in predicting endoscopic remission in rectum in ulcerative colitis
Baseline
Secondary Outcomes (7)
Compare diagnostic accuracy of endoscopic ultrasound in predicting histologic remission
Baseline
Compare diagnostic accuracy of endoscopic ultrasound vascularity in predicting histologic remission
Baseline
Compare diagnostic accuracy of transperineal ultrasound vascularity in predicting histologic remission
Baseline
Compare diagnostic accuracy of transperineal ultrasound in predicting endoscopic remission
Baseline
Compare diagnostic accuracy of transperineal ultrasound in predicting histlogic remission
Baseline
- +2 more secondary outcomes
Study Arms (1)
Adult patients with Ulcerative colitis
OTHERAdult patients (18-75 years) with Ulcerative colitis Pregnant, lactating and acute severe colitis excluded
Interventions
If sigmoidoscopy is warranted as per clinical indication, the consenting patients shall undergo endoscopic ultrasound (EUS) using a radial echo-endoscope during the same sitting of sigmoidoscopy without incurring any additional cost to the patient. Total rectal wall thickness in anterior and posterior wall shall be measured in upper, middle and lower rectum with assessment of vascularity (Modified Limberg scale). The maximal wall thickness including maximum mucosal and submucosal thickness shall be noted and compared to total wall thickness measured by transabdominal ultrasound (TAS) and Transperineal ultrasound (TPUS). On sigmoidoscopy, rectal inflammation shall be measured by ulcerative colitis endoscopic index of severity (UCEIS) in rectum. Biopsy seal be taken as standard protocol to document histologic inflammation (measured by Nancy histologic index) which is known to predict future risk of relapse.
Eligibility Criteria
You may qualify if:
- Adult patients (18-75 years) with Ulcerative colitis
You may not qualify if:
- Pregnant
- Lactating mother
- Endoscopy not required
- No consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Asian Institute of Gastroenterology
Hyderabad, India
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 18, 2024
First Posted
December 5, 2024
Study Start
May 27, 2024
Primary Completion
March 31, 2025
Study Completion
March 31, 2025
Last Updated
July 17, 2025
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share